AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$DGICA

MAHAN JON MARSHALL sold $87K of DGICA

MAHAN JON MARSHALL sold 4,500 shares of DONEGAL GROUP INC (DGICA) at $19.39 on 2026-11-05.

Original reporting
SEC EDGAR · MAHAN JON MARSHALL
Published Nov 5, 2026, 9:19 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 9:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$DGICA
Bearish
medium confidence
Mentioned
$DGICA
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DGICABearishLow
01

Why it matters

The transaction is small relative to the company's market cap and likely has limited price impact.

02

Market read

A routine insider sale with modest size; low trading relevance.

03

What to watch

Potential upcoming corporate actions or personal tax considerations may have driven the sale.

Relevance 3/10Novelty 3/10Timing: today

Background

Form 4 filing discloses a director's open‑market sale of shares.

Company-level read

Ticker impact

$DGICABearishMedium confidence
Context

Director Mahan Jon Marshall sold 4,500 shares of Donegal Group Inc for $87,236 on 2026-11-05.

Expected impact

likely modest pressure as the market prices the insider sell

Evidence & confidence

A 4,500‑share sale representing $87k is small but signals a potential lack of confidence from a director.

Market effects

Sector

Minimal; the sale does not affect the broader sector.

Regional

None; limited to the individual stock.

Global

None

Counterpoint

What could challenge this read

The sale could be routine liquidity need and not indicative of future performance.

Key entities

  • Company
    Donegal Group Inc

    US‑listed biotech company (ticker DGICA).

  • Person
    Mahan Jon Marshall

    Director of Donegal Group Inc.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

DGICA insider trading history →

Related articles

$DGICAMed

Donegal Group Inc (DGICA) Q3 2026 Earnings Call Highlights: Ninth Straight Profitable

Donegal Group (DGICA) reported Q3 2026 earnings, highlighting a 9th straight profitable quarter. CEO Kevin Burke discussed cloud migration timelines and AI integration. Commercial lines saw a 3.2% rise in core loss ratio due to workers' comp and liability losses. Personal lines improved with a 5.4% decline in net premiums written and a 146% increase in new business. Weather-related losses were $19.1M, and investment income rose 5% to $14.7M.

finance.yahoo.com
$DGICAMed

Donegal Group Q3 2026 slides: profitability holds amid soft market

Donegal Group Inc. (DGICA) reported Q3 2026 earnings with adjusted EPS of $0.50, beating estimates, but revenue of $209.7M missed forecasts. Underwriting profitability persisted with a combined ratio of 96.5%, though premiums declined. The stock rose 2.07% premarket. Management highlighted strategic initiatives and conservative investment strategies amid soft market conditions.

investing.com
$DGICAMed

Donegal Group Inc. Announces Third Quarter and First Nine Months of 2026 Results

DONEGAL GROUP INC (DGICA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Donegal Group Inc. Announces Third Quarter and First Nine Months of 2026 Results MARIETTA, Pa., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ: DGICA) and (NASDAQ: DGICB) today reported its financial results for the third quarter and first nine months o

SEC EDGAR 8-K